mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland.
Matthias Peter HiltyStefanie KeiserPedro D Wendel GarciaAndré MoserReto A Schuepbachnull nullPublished in: Intensive care medicine (2022)